PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?
| Image |  |
|---|---|
| Description | scientific article published on 16 February 2018 |
| Author/s |
author: Paul A VanderLaan |
| Publication date | February 16, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |